Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
218 studies found for:    "Carcinoma, Basal Cell"
Show Display Options
Rank Status Study
1 Suspended Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas
Conditions: Skin Cancers;   Carcinoma, Basal Cell;   Skin Cancer;   Basal Cell Carcinoma
Intervention: Drug: Itraconazole
2 Completed Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
3 Terminated Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Conditions: Basal Cell Carcinoma;   Nevoid Basal Cell Carcinoma Syndrome;   Gorlin Syndrome
Intervention: Drug: verteporfin PDT
4 Unknown  Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Intervention: Drug: Imiquimod 5% cream
5 Suspended Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
Condition: Carcinoma, Basal Cell
Interventions: Procedure: Curettage;   Procedure: Deep excision;   Procedure: Shave excision
6 Enrolling by invitation Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970
Condition: Carcinoma, Basal Cell
Interventions: Procedure: 3D-histology;   Procedure: Shave excision
7 Completed Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Intervention: Drug: Imiquimod
8 Not yet recruiting Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: questionnaire administration
9 Completed Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Radiation: photodynamic therapy
10 Completed
Has Results
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Radiation: photodynamic therapy
11 Completed Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear
Conditions: Carcinoma, Basal Cell;   Porokeratosis, Disseminated Superficial Actinic
Intervention: Procedure: Skin scrape
12 Not yet recruiting One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
Condition: Carcinoma, Basal Cell
Interventions: Device: Reflectance confocal microscopy;   Procedure: Punch biopsy;   Procedure: Surgical excision
13 Unknown  Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)
Condition: Carcinoma, Basal Cell
Intervention:
14 Completed A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Interventions: Procedure: standard surgery;   Procedure: Mohs micrographic surgery
15 Recruiting Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
Condition: Superficial Basal Cell Carcinoma
Interventions: Drug: Methylaminolevulinate PDT in 2 sessions;   Drug: Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
16 Recruiting New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Conditions: Skin Neoplasms;   Carcinoma, Basal Cell
Interventions: Drug: MAL-PDT re-treatment;   Drug: usual MAL-PDT
17 Active, not recruiting A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: LDE225
18 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: PEP005
19 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: PEP005
20 Completed Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Interventions: Procedure: PDT with Metvix 160 mg/g cream;   Procedure: PDT with placebo cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years